// App-Quantinova.ai

391 : Natural history of patients with advanced cholangiocarcinoma and FGFR2 gene fusions/rearrangements.

Researchers

Presenter

  • Rachna T. Shroff

Principal Investigators

  • Francesca Avogadri

  • Richard Weng

  • Ai Li

  • Carl L. Dambkowski

  • Angela Lamarca

Medical Centers

  • University of Arizona Cancer Center, Tucson, AZ

  • Halozyme Therapeutics, Inc., San Francisco, CA

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Solid malignancies

Biomarkers

  • Fibroblast Growth Factor Receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved